Cipla Plans Open Access To HIV Drug Patent
  • Prabha Hedge
  • Mar 11 2014

March 11: Cipla is hoping to revolutionize the treatment of HIV-AIDS in infants and children. Mint has reported that Cipla, which will own the intellectual property rights of a new anti-retroviral combination therapy, plans to put the technology in a free access patent pool. Mint’s C.H. Unnikrishnan shares a detailed report on the same.